skip to primary navigationskip to content
 

11.02.19 Steve Jackson to receive the ARC Foundation's Léopold Griffuel Award

last modified Feb 13, 2019 11:03 AM
Steve Jackson wins prestigious cancer research award from the Fondation ARC pour la recherche sur le cancer

The Fondation ARC Léopold Griffuel Award

...is a prestigious European cancer research prize that has been awarded annually since 1970.

Fondation ARC is the largest French foundation dedicated entirely to cancer research, and is funded by public donations. Their mission is to support research in the fight to eradicate cancers, with an ambitious goal "to cure 2 cancers out of 3 by 2025".

The award winners are scientists and physicians who have made an important contribution to better understand, diagnose, cure and prevent cancers. The award was created according to the will of the late Mrs Griffuel by bequest, in honour and memory of her late husband, Mr. Léopold Griffuel.

Fondation ARC has announced that two outstanding scientists will receive awards, including prizes of Euro 150,000, in 2019:

In Basic Research, Prof. Laurence Zitvogel (UMR Inserm) for her research in immunology, which improved the understanding of the biological mechanisms of the anticancer immune response and immunotherapies. Her discoveries have changed the way the immune system is understood in relation to cancer treatment.

In Translational and Clinical Research, Prof. Steve Jackson (Wellcome/ Cancer Research UK Gurdon Institute) for his work on DNA damage repair and his role in the development of medicines such as PARP1 and 2 inhibitors, currently used for cancer treatment.

Prof Jackson said: "I am deeply honoured and delighted to be given this prestigious award for my research, which has been translated into patient benefit. The field of DNA damage repair has expanded substantially in recent years and continues to provide us with new avenues for understanding the causes of cancer, and identifying new therapeutic targets."

The Fondation ARC also announced that an award ceremony will take place in honour of the laureates on 10th April at the Salon de l’hôtel des Arts et Métiers in Paris, France.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018

 

Share this

A walk through tau therapeutic strategies

Labeling strategies matter for super-resolution microscopy: a comparison between HaloTags and SNAP-tags

Stem Cell-Derived Human Gametes: The Public Engagement Imperative

Tissue- and sex-specific small RNAomes reveal sex differences in response to the environment

Comparative Epigenomics Reveals that RNA Polymerase II Pausing and Chromatin Domain Organization Control Nematode piRNA Biogenesis

Pluripotency and X chromosome dynamics revealed in pig pre-gastrulating embryos by single cell analysis

Constrained actin dynamics emerges from variable compositions of actin regulatory protein complexes

Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia

Drosophila IMP regulates Kuzbanian to control the timing of Notch signalling in the follicle cells

Challenges in unsupervised clustering of single-cell RNA-seq data

Engineering vasculature: Architectural effects on microcapillary-like structure self-assembly

ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks

Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer’s Disease

Helicase subunit Cdc45 targets the checkpoint kinase Rad53 to both replication initiation and elongation complexes after fork stalling

Competition for Mitogens Regulates Spermatogenic Stem Cell Homeostasis in an Open Niche

Link to full list on PubMed